Latest news
A Quick Look at Today's Ratings for Cartesian Therapeutics(RNAC.US), With a Forecast Between $25 to $44 - MoomooMoomoo · Sat, 08 Aug 2026 04:51:21 GMTCartesian Therapeutics Inc (RNAC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 16:24:49 GMTCartesian Therapeutics Inc (RNAC) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 13:30:25 GMTFour new employees get options for 115,250 Cartesian shares - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTCartesian Therapeutics Announces New Employment Inducement Grants - SahmSahm · Fri, 07 Aug 2026 07:00:00 GMTCartesian Therapeutics 2Q Research and Development Expenses $20.4M >RNAC - MoomooMoomoo · Fri, 07 Aug 2026 00:42:08 GMTCartesian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:48:34 GMTCartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMT